NLRP3 and chronic obstructive pulmonary disease: Taken together, there is ample evidence of IL-1 cytokines and inflammasome activation in stable and exacerbated COPD but whether NLRP3 activation drives disease progression and the mechanism behind it is yet to be elucidated.